These constraints on the BTNX NTS are really pertinent, as we uncovered e.g. etodesnitazene to have an identical in vitro potency and efficacy as fentanyl [seven, thirteen] and as it may well probably give PWUD a false sense of security. On top of that, the detectability of nitazene analogues in drug samples could be impacted by solubility issues,